Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of OnabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial
Chang E, Ringel N, Woodburn K, Tanner J, Bassaly R, Greene K, Wyman A, Iglesia C. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of OnabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial. Obstetrical & Gynecological Survey 2022, 77: 650-651. DOI: 10.1097/ogx.0000000000001102.Peer-Reviewed Original ResearchOveractive bladderNonneurogenic overactive bladderThird-line therapyΒ-agonist therapyAmerican Urological AssociationFemale pelvic medicineSociety of UrodynamicsIntradetrusor injectionsPain AssociatedTreatment episodesClinical trialsUrological AssociationPelvic medicineBladderTherapyBehavioral changesInjectionWide variationMulticenterOnabotulinumtoxinACholinergicUrodynamicsTrialsPostprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial
Chang E, Ringel N, Woodburn K, Tanner J, Bassaly R, Greene K, Wyman A, Iglesia C. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial. Urogynecology 2022, 28: 518-525. PMID: 35543540, DOI: 10.1097/spv.0000000000001199.Peer-Reviewed Original ResearchConceptsUrgency urinary incontinenceOveractive bladderProcedure timeIntradetrusor injectionsAdverse eventsUrinary incontinenceClinical trialsSubjective efficacyAverage pain scoreGlobal response assessmentRefractory overactive bladderIdiopathic overactive bladderVisual analog scalePain scoresOnabotulinumtoxinA treatmentPain AssociatedPain levelsWeeks postprocedurePostprocedure complicationsAnalog scaleProcedure durationResponse assessmentPatient experiencePatientsInjection paradigm